Pentazocine
- Generic Name
- Pentazocine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H27NO
- CAS Number
- 359-83-1
- Unique Ingredient Identifier
- RP4A60D26L
- Background
The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97)
- Indication
For the relief of moderate to severe pain.
- Associated Conditions
- Mild pain, Severe Pain, Moderate Pain
- Associated Therapies
- Anesthetic premedication therapy
Opioid-free Analgesia for the Management of Acute Post-operative Pain Following Caesarean Section
Not Applicable
Completed
- Conditions
- Acute Post-operative Pain Following Caesarean Section
- Interventions
- First Posted Date
- 2020-09-04
- Last Posted Date
- 2023-07-20
- Lead Sponsor
- Olakunle Ifeoluwa Makinde
- Target Recruit Count
- 324
- Registration Number
- NCT04539249
- Locations
- 🇳🇬
Federal Medical Centre, Yenagoa, Yenagoa, Bayelsa State, Nigeria
The Feasibility of Different Doses of Etomidate Admixed With Propofol in Induced Abortion: A Randomized, Double Blind Controlled Trial
Phase 4
- Conditions
- Induced AbortionAnesthesia
- Interventions
- First Posted Date
- 2014-08-05
- Last Posted Date
- 2014-08-05
- Lead Sponsor
- Third Affiliated Hospital of Zhengzhou University
- Target Recruit Count
- 150
- Registration Number
- NCT02208596
Effects of Pentazocine Versus Lorazepam on Manic Symptoms
Phase 2
Completed
- Conditions
- Bipolar DisorderSchizoaffective DisorderManic DisorderManiaManic State
- Interventions
- First Posted Date
- 2007-02-05
- Last Posted Date
- 2019-03-06
- Lead Sponsor
- Mclean Hospital
- Target Recruit Count
- 19
- Registration Number
- NCT00431184
- Locations
- 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath